pfizer

6+ articles

2026 AI COVID-19 Elon Musk GSK

Elon Musk Adds Fuel to COVID-19 Vaccine Debate: Claims of Media Silence and Severe Side Effects!

In a fiery twist in the ongoing COVID-19 vaccine saga, Elon Musk has reignited discussions by supporting Dr. Helmut Sterz's controversial claims about the rushed development and alleged dangers of mRNA vaccines. During a German parliamentary hearing, former pharmaceutical toxicologist Sterz highlighted skipped safety tests and unverified adverse events associated with Pfizer's vaccine, sparking media coverage and social debate. Musk's social media amplification adds to the clamor for deeper scrutiny.

Apr 13

Elon Musk Adds Fuel to COVID-19 Vaccine Debate: Claims of Media Silence and Severe Side Effects!

Elon Musk Reignites COVID-19 Vaccine Controversy with Ex-Pfizer Expert

Elon Musk has sparked renewed debate over COVID-19 vaccine safety after amplifying claims from John Fraser, a former Pfizer toxicologist, on potential DNA contamination in mRNA vaccines. Musk's involvement this time centers around Fraser's allegations that Pfizer's vaccines contain "excessive" plasmid DNA, which might pose health risks. Despite pushback from health experts and regulatory bodies reaffirming vaccine safety, the controversy has reignited vaccine hesitancy and divided public opinion.

Apr 13

Elon Musk Reignites COVID-19 Vaccine Controversy with Ex-Pfizer Expert

Elon Musk Sparks Controversy with Endorsement of Vaccine Critic

Elon Musk recently added fuel to the fire of the COVID-19 vaccine debate by endorsing claims made by Dr. Helmut Sterz, a former Pfizer toxicologist. Musk's comments on social media highlighted his personal adverse reaction to the vaccine, sparking polarized reactions and renewed scrutiny over vaccine safety in Germany. This comes amidst continuing discussions on the accuracy of death reports linked to the Pfizer Comirnaty vaccine.

Apr 13

Elon Musk Sparks Controversy with Endorsement of Vaccine Critic

QuantumLeap Dynamics Achieves Practical Quantum Supremacy in Drug Discovery

QuantumLeap Dynamics, a Bay Area startup, has made a significant breakthrough in quantum computing by achieving stable quantum supremacy for simulating complex molecular structures. This feat, achieved with a 1,024-qubit processor, can drastically reduce drug development timelines, raising both excitement and ethical discussions around AI-driven medicine.

Jan 24

QuantumLeap Dynamics Achieves Practical Quantum Supremacy in Drug Discovery

Novo Nordisk Combines Major Layoffs with 2026 Return-to-Office Mandate!

Novo Nordisk, the pharmaceutical giant, is asking workers to return to the office by 2026 following the announcement of 9,000 job cuts globally. This strategic shift aims to focus on key areas such as diabetes and obesity treatments. The move reflects broader industry trends seen in 2025, with competitors like Bayer and Pfizer also rethinking workplace policies amid cost-saving efforts.

Sep 12

Novo Nordisk Combines Major Layoffs with 2026 Return-to-Office Mandate!

Pfizer Sells 700 Million Haleon Shares, Pocketing $3.05 Billion!

In a strategic move, Pfizer has sold 700 million shares of Haleon, garnering $3.05 billion. This divestiture aligns with Pfizer's post-spinoff strategy and grants the pharma giant a substantial cash infusion for R&D and potential acquisitions. Meanwhile, Haleon's business remains steady, though its market valuation might see fluctuations from this block sale. Pfizer continues to streamline its operations post its consumer healthcare spinoff, paving the path for focused pharmaceutical advancements.

Jan 17

Pfizer Sells 700 Million Haleon Shares, Pocketing $3.05 Billion!